Works matching IS 00302414 AND DT 2018 AND VI 94 AND IP 1


Results: 9
    1
    2
    3

    An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204).

    Published in:
    Oncology, 2018, v. 94, n. 1, p. 39, doi. 10.1159/000480295
    By:
    • Berlin, Jordan D.;
    • Feng, Yang;
    • Catalano, Paul;
    • Abbruzzese, James L.;
    • Philip, Philip A.;
    • McWilliams, Robert R.;
    • Lowy, Andrew M.;
    • Benson III, Al B.;
    • Blackstock, A. William
    Publication type:
    Article
    4
    5
    6
    7
    8
    9